{"id":3573,"date":"2023-11-12T18:08:25","date_gmt":"2023-11-12T18:08:25","guid":{"rendered":"\/?p=3573"},"modified":"2023-11-13T04:35:38","modified_gmt":"2023-11-13T04:35:38","slug":"gui-dong-zhu","status":"publish","type":"post","link":"\/?p=3573","title":{"rendered":"Gui-Dong Zhu"},"content":{"rendered":"\n<p>Gui-Dong Zhu is the founder and CEO of the SparX Group. He is a 27-year veteran in pharmaceutical industry, 22 Years with various leadership responsibilities at Abbott\/Abbvie, contributing to the development of one product and six candidates in different stages of clinical trials. Following the incorporation of SparX Group in 2018, Gui-Dong built sophisticated and integrated technology platforms for antibody development including the SparxNano platform for the discovery of highly potent and specific single domain antibodies and the SynMab<sup>TM<\/sup> platform for optimization of multi-specific antibodies. Gui-Dong also has expertise in other aspects of pharmaceutical research including structural biology, drug delivery, antibody manufacturing, and all phases of preclinical studies. Gui-Dong is author or co-author of more than one hundred publications of original papers, reviews, patents and presentations, along with over six hundred commentaries. Gui-Dong has also been an invited and plenary speaker in a number of venues both nationally and internationally.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Gui-Dong Zhu is the founder and CEO of the SparX Group. He is a 27-year veteran in pharmaceutical industry, 22 Years with various leadership responsibilities at Abbott\/Abbvie, contributing to the development of one product and six candidates in different stages of clinical trials. Following the incorporation of SparX Group in 2018, Gui-Dong built sophisticated and [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":3574,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[52],"tags":[],"_links":{"self":[{"href":"\/index.php?rest_route=\/wp\/v2\/posts\/3573"}],"collection":[{"href":"\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=3573"}],"version-history":[{"count":2,"href":"\/index.php?rest_route=\/wp\/v2\/posts\/3573\/revisions"}],"predecessor-version":[{"id":3586,"href":"\/index.php?rest_route=\/wp\/v2\/posts\/3573\/revisions\/3586"}],"wp:featuredmedia":[{"embeddable":true,"href":"\/index.php?rest_route=\/wp\/v2\/media\/3574"}],"wp:attachment":[{"href":"\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=3573"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=3573"},{"taxonomy":"post_tag","embeddable":true,"href":"\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=3573"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}